{"nct_id":"NCT06577025","title":"A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-08-20","start_date_type":"ACTUAL","primary_completion_date":"2030-07-31","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09-02","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}